Nicotine, acting through nicotinic acetylcholine receptors (nAChR) loc
ated on nerve terminals, can evoke the release of various neurotransmi
tters in the brain. The presynaptic nicotinic stimulation of acetylcho
line release, demonstrated in cortical and hippocampal preparations, m
ay reflect a positive feedback mechanism via autoreceptors. This site
is a target for novel nicotinic agonists in the symptomatic treatment
of Alzheimer's disease. Nicotinic heteroreceptors can modulate the rel
ease of catecholamines and amino acid transmitters in diverse brain re
gions. Differences in agonist potency and efficacy and in antagonist s
ensitivities between different transmitter pathways suggests heterogen
eity of subtypes of presynaptic nAChR (notably between alpha 3- and al
pha 4-containing nAChR). While neurochemical studies have failed to fi
nd any evidence for the involvement of alpha 7-type nAChR in the presy
naptic modulation of transmitter release, recent electrophysiological
studies have disclosed this as a possibility with respect to glutamate
transmission. Investigation of the mechanisms coupling nAChR activati
on to exocytosis suggests that despite their high relative permeabilit
y to Ca2+, nAChR on striatal terminals promote dopamine release by ope
ning voltage-sensitive Ca2+ channels, principally N-type channels. Com
parison of in vitro preparations with in vivo studies confirms that ni
cotine (administered via a microdialysis probe) can elicit dopamine re
lease from the terminal fields of the three major dopamine pathways: T
his is dose dependent and mecamylamine sensitive. However, release fro
m striatum and accumbens (but not frontal cortex) is completely blocke
d by tetrodotoxin, compared with a partial block (40%) of release from
synaptosomes. In vivo, nicotine may be able to influence dopamine rel
ease by acting on 1) ''pre-terminal'' nAChR, 2) presynaptic nAChR on a
djacent glutamatergic terminals, or 3) local interneurones bearing nAC
hR, in addition to a direct action th rough presynaptic nAChR on dopam
inergic terminals. Thus, a complex picture is emerging of various loci
at which nicotine and other agonists can act through a variety of nAC
hR subtypes to influence neurotransmitter release: The significance of
this phenomenon for synaptic transmission is discussed. (C) 1996 Wile
y-Liss, Inc.